54 107 (Lithium 300 mg)

Pill imprint 54 107 has been identified as Lithium carbonate extended release 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; depression; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 54 107 (Lithium 300 mg)

Lithium carbonate extended release 300 mg 54 107
Lithium carbonate extended release 300 mg 54 107  Front
Lithium carbonate extended release 300 mg 54 107  Back
Lithium carbonate extended release 300 mg 54 107
Lithium carbonate extended release
Imprint:
54 107
Strength:
300 mg
Color:
Beige
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-0021
Inactive Ingredients:
calcium stearate
povidone
sodium chloride
sodium lauryl sulfate
sorbitol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0412 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)